HCS Pharma

HCS Pharma is a biotechnology company focused on in vitro R&D. HCS Pharma manufactures and sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® Hydroscaffold™. BIOMIMESYS® 3D culture technology faithfully reproduces the natural 3D cells microenvironment , including matrix architecture, cellular organization, biological cell-cell and biomechanical cell-matrix interactions with fully natural compounds.
BIOMIMESYS® matrices are made of Hyaluronic Acid (HA), the main glycosaminoglycan (GAG) of the ECM, collagens and adhesion proteins. Our patented manufacturing process complies with the green chemistry convention allow preserving the natural properties of HA and therefore synthesizing proprietary Hydroscaffold™. Depending on the tissue needed extracellular matrix components may change as well their proportions, allowing a soft or a stiff cellular environment.
The exclusive BIOMIMESYS® technology from HCS Pharma is used in the Eurostar ScaLABle-MEAT project to invent the next generation of food - sustainable, safe and respectful to animals.

Primary focus
Location
Founded
2014
Website
hcs-pharma.com
Business model
Protein category
Technology focus

Would you like to request an edit?

Suggest edit
Mentioned in:
Get our monthly brief: featuring top companies and networking opportunities.
Newsletter CTA
By subscribing, you are agreeing to occasionally receive information about our relevant products and services.
Learn more about the opportunities in
cellular agriculture and cultivated meat.
Explore cultivated meat

Related alt protein companies

© Protein Directory. All rights reserved.
envelope linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram